Category: Biotechnology
Global Biotechnology
-
Rare Disease Genetic Testing Market by Disease Type (Cancer, Cardiovascular Disorders, Dermatology Diseases), Technology (Array Technology, FISH, Karyotyping), Specialty, End-User - Global Forecast 2024-2030
... 1.33 billion in 2023 and expected to reach USD 1.54 billion in 2024, at a CAGR 16.15% to reach USD 3.80 billion by 2030. Rare disease genetic testing refers to the process of analyzing DNA, ... Read More
-
Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.68 billion in 2024, at a CAGR 10.82% to reach USD 8.70 billion by 2030. The gene synthesis market comprises technologies, products, and services related to the artificial ... Read More
-
Biosimulation Market by Offering (Services, Software), Delivery Model (Ownership Models, Subscription Models), End-User, Application - Global Forecast 2024-2030
... 4.40 billion in 2024, at a CAGR 14.55% to reach USD 9.87 billion by 2030. Biosimulation combines mathematics, biology, and computer programming to create simulations to test hypotheses, predict outcomes, and explore new possibilities in ... Read More
-
Artificial Intelligence in Regenerative Medicine Market by Technology (Computer Vision, Context-Aware Computing, Machine Learning), Offering (Hardware, Services, Software), Application, End-User - Global Forecast 2024-2030
... USD 59.63 million in 2023 and expected to reach USD 72.38 million in 2024, at a CAGR 22.05% to reach USD 240.63 million by 2030. Artificial intelligence (AI) is increasingly important in regenerative medicine as ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Microcarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide a surface ... Read More
-
Process Spectroscopy Market by Technology (Atomic Spectroscopy, Mass Spectroscopy, Molecular Spectroscopy), Component (Hardware, Software), Application - Global Forecast 2024-2030
... reach USD 22.57 billion in 2024, at a CAGR 9.93% to reach USD 40.25 billion by 2030. Process spectroscopy includes various spectroscopic instruments and software solutions that facilitate real-time analysis of chemical, physical, and biological ... Read More
-
dPCR & qPCR Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical Application, Forensic Applications, Research Application), End-User - Global Forecast 2024-2030
... 8.05 billion in 2023 and expected to reach USD 8.88 billion in 2024, at a CAGR 10.23% to reach USD 15.94 billion by 2030. Digital PCR (dPCR) refers to a measurement technique that provides an ... Read More
-
Continuous Bioprocessing Market by Product (Bioreactors, Cell Culture Media & Reagent, Centrifuges), Process (Downstream Bioprocess, Upstream Bioprocess), Application, Scale of Operation, End-User - Global Forecast 2024-2030
... 233.44 million in 2023 and expected to reach USD 282.42 million in 2024, at a CAGR 21.30% to reach USD 902.23 million by 2030. Continuous bioprocessing represents a paradigm shift in the production of biopharmaceutical ... Read More
-
Pharmacogenomics Market by Product (Consumables, Kits & Reagents, Services), Technology (DNA Sequencing, Electrophoresis, Mass Spectrometry), Indication, Application - Global Forecast 2024-2030
... to reach USD 4.48 billion in 2024, at a CAGR 10.54% to reach USD 8.20 billion by 2030. The pharmacogenomics market encompasses the study of genetic variations influencing an individual's response to drugs. Pharmacogenomics combines ... Read More
-
Cancer Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Cancer Type, Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.72 billion in 2023 and expected to reach USD 5.21 billion in 2024, at a CAGR 10.55% to reach USD 9.54 billion by 2030. Cancer stem cells are cells found within tumors ... Read More
-
Cell Therapy Market by Cell Type (Differentiated Cell, Stem Cell), Therapy Type (Allogenic Therapies, Autologous Therapies), Application, End-User - Global Forecast 2024-2030
... and expected to reach USD 9.60 billion in 2024, at a CAGR 10.93% to reach USD 17.91 billion by 2030. The cell therapy market encompasses the research, development, manufacturing, and commercialization of products and techniques ... Read More
-
Mesenchymal Stem Cells Market by Type (Allogeneic, Autologous), Indication (Bone & Cartilage Repair, Cancer, Cardiovascular Disease), Source of Isolation, Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.98 billion in 2024, at a CAGR 13.63% to reach USD 8.59 billion by 2030. Mesenchymal stem cells (MSCs) are multipotent stromal cells that can differentiate into ... Read More
-
Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 7.05 billion in 2024, at a CAGR 27.15% to reach USD 30.48 billion by 2030. Gene therapy is a medical procedure that introduces, alters, or corrects genetic ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Biomarker Testing Services Market by Services (Biomarker Assay Development & Validation, Flow Cytometry), Techonology (Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Next-Generation Sequencing), Disease Area, Application, End-User - Global Forecast 2024-2030
... was estimated at USD 964.90 million in 2023 and expected to reach USD 1,031.96 million in 2024, at a CAGR 7.34% to reach USD 1,585.04 million by 2030. Biomarker testing services refer to the clinical ... Read More
-
Oxidative Stress Assay Market by Product & Service (Consumables, Instruments, Services), Test Type (Antioxidant Capacity Assays, Enzyme-Based Assays, Indirect Assays), Technology, End-user, Indication - Global Forecast 2024-2030
... at USD 1.06 billion in 2023 and expected to reach USD 1.17 billion in 2024, at a CAGR 10.85% to reach USD 2.19 billion by 2030. The oxidative stress assay is a bioanalytical method to ... Read More
-
Cardiac Marker Testing Market by Product (Instruments, Reagents & Kits), Biomarker (BNP Or NT-ProBNP, Ceratine Kinase-MB, hs-CRP), Type of Testing, Disease - Global Forecast 2024-2030
... 5.10 billion in 2023 and expected to reach USD 5.50 billion in 2024, at a CAGR 7.90% to reach USD 8.69 billion by 2030. Cardiac marker testing market consists of the spectrum of medical technologies ... Read More
-
Preimplantation Genetic Testing Market by Technology (Comparative Genomic Hybridization, Fluorescence in-Situ Hybridization, Next-Generation Sequencing), Offering (Instruments, Reagents & Consumables, Software & Services), Procedure Type, Application, End User - Global Forecast 2024-2030
... Market size was estimated at USD 728.40 million in 2023 and expected to reach USD 829.06 million in 2024, at a CAGR 14.56% to reach USD 1,886.28 million by 2030. Preimplantation genetic testing (PGT) refers ... Read More
-
Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), Туре (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2024-2030
... at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030. Clinical trial supplies are a fundamental yet complex component ... Read More
-
Next-Generation Cancer Diagnostics Market by Technology (Clustered Regularly Interspaced Short Palindromic Repeats Diagnostics, DNA Microarrays, Lab-on-a-Chip & Reverse Transcriptase-PCR), Cancer Type (Bladder Cancer, Breast Cancer, Cervical Cancer), Application, Function - Global Forecast 2024-2030
... Cancer Diagnostics Market size was estimated at USD 9.77 billion in 2023 and expected to reach USD 12.02 billion in 2024, at a CAGR 24.12% to reach USD 44.36 billion by 2030. The next-generation cancer ... Read More
-
Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application - Global Forecast 2024-2030
... reach USD 2.53 billion in 2024, at a CAGR 10.75% to reach USD 4.70 billion by 2030. Biopharmaceutical excipients are substances other than therapeutic molecules that are included in a biopharmaceutical formulation to aid in ... Read More
-
Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Global Forecast 2024-2030
... 46.76 billion in 2024, at a CAGR 7.63% to reach USD 73.03 billion by 2030. The insulin market encompasses the production, distribution, and consumption of various insulin types used to treat diabetes mellitus, a chronic ... Read More
-
Life Science Tools Market by Technology (Cell Biology Technology, Genomic Technology, Proteomics Technology), Product (Cell Culture Systems & 3D Cell Culture, Cloning & Genome Engineering, Flow Cytometry), Offerings, Lab Ownership, Lab Size, End-User - Global Forecast 2024-2030
... Forecast 2024-2030 The Life Science Tools Market size was estimated at USD 203.93 billion in 2023 and expected to reach USD 226.14 billion in 2024, at a CAGR 11.21% to reach USD 429.19 billion by ... Read More
-
Dietary Supplement Testing Services Global Market Opportunities And Strategies To 2033 Including: 1) By Service: Stability Testing; Analytical Testing; Microbiological Testing; Regulatory Testing And Compliance 2) By Ingredient: Herbal; Vitamins; Minerals; Amino Acids; Enzymes 3) By Service Provider: Testing Laboratories; Contract Research Organizations (CROs); Regulatory Consultants 4) By End-User: Manufacturers; Contract Manufacturers; Distributors; Regulatory Bodies Covering: Eurofins Scientific SE; Quest Diagnostics Inc.; UL LLC (Underwriters Laboratories); Herbalife Nutrition Ltd.; Covance Laboratories Inc.
... testing services market as it emerges from the COVID-19 shut down. Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. • Understand how ... Read More
Research Assistance
